Advertisement
DOCS vs HNGE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOCS is a Hold and HNGE is a Hold.
DOCS in downward trend: price may drop because broke its higher Bollinger Band on October 20, 2026
DOCS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 34 similar instances where the stock broke above the upper band. In 27 of the 34 cases the stock fell afterwards. This puts the odds of success at 79%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for DOCS moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 19 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 56 cases where DOCS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DOCS as a result. In 59 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for DOCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 34 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
Bullish Trend Analysis
The 50-day moving average for DOCS moved above the 200-day moving average on October 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCS advanced for three days, in 210 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 126 of 181 cases where DOCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. DOCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.326) is normal, around the industry mean (4.477). P/E Ratio (36.122) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.590) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (7.776) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Aroon Indicator for HNGE shows an upward move is likely
HNGE's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 76 similar instances where the Aroon Indicator showed a similar pattern. In 67 of the 76 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where HNGE advanced for three days, in 82 of 96 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 11 of 15 cases where HNGE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HNGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
HNGE broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 25 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. HNGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HNGE's P/B Ratio (27.129) is slightly higher than the industry average of (4.477). P/E Ratio (14.015) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (10.504) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HNGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
| DOCS | HNGE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 76% | N/A |
| MACD ODDS (%) | 2 days ago 77% | N/A |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 86% |
| Advances ODDS (%) | 15 days ago 75% | 2 days ago 85% |
| Declines ODDS (%) | 6 days ago 78% | 6 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DOCS’s FA Score shows that 0 FA rating(s) are green while HNGE’s FA Score has 2 green FA rating(s).
- DOCS’s FA Score: 0 green, 5 red.
- HNGE’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DOCS’s TA Score shows that 3 TA indicator(s) are bullish while HNGE’s TA Score has 2 bullish TA indicator(s).
- DOCS’s TA Score: 3 bullish, 6 bearish.
- HNGE’s TA Score: 2 bullish, 4 bearish.
Price Growth
DOCS (@Services to the Health Industry) experienced а -0.55% price change this week, while HNGE (@Services to the Health Industry) price change was +5.47% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.21%. For the same industry, the average monthly price growth was +2.13%, and the average quarterly price growth was +27.96%.
Reported Earning Dates
DOCS is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Services to the Health Industry (+0.21% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
DOCS and
Correlation & Price change
A.I.dvisor indicates that over the last year, DOCS has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DOCS jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To DOCS | 1D Price Change % | ||
|---|---|---|---|---|
| DOCS | 100% | -1.37% | ||
| COIN - DOCS | 57% Loosely correlated | -2.92% | ||
| PUBM - DOCS | 54% Loosely correlated | -10.90% | ||
| CLSK - DOCS | 53% Loosely correlated | -4.92% | ||
| COMP - DOCS | 53% Loosely correlated | -7.41% | ||
| RIOT - DOCS | 49% Loosely correlated | +2.38% | ||
More | ||||
HNGE and
Correlation & Price change
A.I.dvisor indicates that over the last year, HNGE has been loosely correlated with OMDA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if HNGE jumps, then OMDA could also see price increases.
| Ticker / NAME | Correlation To HNGE | 1D Price Change % | ||
|---|---|---|---|---|
| HNGE | 100% | +0.85% | ||
| OMDA - HNGE | 54% Loosely correlated | -0.20% | ||
| TEM - HNGE | 35% Loosely correlated | -4.62% | ||
| TDOC - HNGE | 34% Loosely correlated | -0.45% | ||
| DOCS - HNGE | 32% Poorly correlated | -1.37% | ||
| VEEV - HNGE | 31% Poorly correlated | -0.28% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PTL | 268.03 | 0.34 | +0.13% |
| Inspire 500 ETF (PTL) | |||
| FTHB | 24.45 | -0.21 | -0.84% |
| FIS Faith Income ETF (FTHB) | |||
| EPRF | 15.53 | -0.19 | -1.21% |
| Innovator S&P Investment Grade Preferred ETF (EPRF) | |||
| GDX | 86.49 | -4.97 | -5.43% |
| VanEck Gold Miners ETF (GDX) | |||
| ETHT | 10.88 | -0.80 | -6.85% |
| ProShares Ultra Ether ETF (ETHT) | |||